Prot# H8K-MC-JZAD: A Phase 2 Study of LY573636-sodium Administered as Second-Line or Third-Line Treatment in Patients with Unresectable or Metastatic Soft Tissue Sarcoma

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date8/23/078/23/10

    Funding

    • The University of Chicago (38083-01 // P50 GM081892)
    • National Institute of General Medical Sciences (38083-01 // P50 GM081892)